As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
- Overall Trial
- Study Sites (6)
A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)
Purpose / Objectives
- Phase II
- Phase III
Documents (password protected)
Responsibilities in overall trial
G. Pohl-Boskamp GmbH & Co. KG
National Coordinating Investigator
Univ.-Prof. Dr. med. Michael Dreher